课题基金 / 基金详情

Sodium selenate reverses drug resistant temporal lobe epilepsy

Sodium selenate reverses drug resistant temporal lobe epilepsy
硒酸钠可逆转耐药颞叶癫痫
批准号:
nhmrc : GNT1166170
负责人:
Dr Pablo Casillas Espinosa
金额:
$32.72万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Temporal lobe epilepsy is often resistant to treatment. The seizures and the associated psychiatric disorders associated with acquired epilepsy seriously affect the quality of life of patients. This study investigates a novel treatment target that could improve the symptoms of the disease to a point that no further therapy may be required.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金